Psoriatic arthritis (PsA) affects roughly 30% of patients with psoriasis, yet no 2 cases look alike, says Philip Mease, MD, director of rheumatology and research, Providence Swedish Medical Center, ...
Otezla (apremilast) is an oral tablet commonly used to treat psoriatic arthritis in adults. Psoriatic arthritis is a long-lasting condition that affects the joints in people with psoriasis. Common ...
If you’re one of the millions of people dealing with psoriatic arthritis, you know just how frustrating it can be. One day, you’re moving just fine and the next, you’re hit with joint pain, stiffness ...
Failure to respond to targeted disease-modifying antirheumatic drugs (tsDMARDs) for psoriatic arthritis occurs at an incident rate of about 0.35 per person-year. An observational cohort of 591 ...
Exploring whether different joints have different treatment outcomes in cases of psoriatic arthritis
There are many treatment options for psoriatic arthritis (PsA), and EULAR—The European Alliance of Associations for Rheumatology—recommends a practical and progressive approach to management based on ...
Editor’s note: This is an automatically generated transcript. Please notify [email protected] if there are concerns regarding accuracy of the transcription. So talking about treatment options in a ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Clinicians ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results